製品の概要

  • 製品名Recombinant Human RFC3 protein
  • タンパク質長Full length protein

製品の詳細

  • 由来Recombinant
  • 由来Escherichia coli
  • アミノ酸配列
    • 生物種Human

関連製品

特性

Our Abpromise guarantee covers the use of ab40209 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • アプリケーション

    SDS-PAGE

  • 精製度> 95 % SDS-PAGE.

  • 製品の状態Liquid
  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped at 4°C. Upon delivery aliquot. Store at -80°C. Avoid freeze / thaw cycle.

    Preservative: 0.002% Sodium Azide
    Constituents: 10mM Tris, 0.1% Triton X-100, pH 8.

関連情報

  • 別名
    • A1 38 kDa subunit
    • Activator 1 38 kDa subunit
    • Activator 1 subunit 3
    • HGNC:9971
    • MGC5276
    • Replication factor C (activator 1) 3
    • Replication factor C (activator 1) 3, 38kDa
    • Replication factor C 3
    • Replication factor C 38 kDa subunit
    • Replication factor C subunit 3
    • RF-C 38 kDa subunit
    • RFC 38 kD subunit
    • RFC 38 kDa subunit
    • RFC3
    • RFC3_HUMAN
    • RFC38
    see all
  • 機能The elongation of primed DNA templates by DNA polymerase delta and epsilon requires the action of the accessory proteins proliferating cell nuclear antigen (PCNA) and activator 1.
  • 配列類似性Belongs to the activator 1 small subunits family.
  • 翻訳後修飾Phosphorylated upon DNA damage, probably by ATM or ATR.
  • 細胞内局在Nucleus.
  • Information by UniProt

Recombinant Human RFC3 protein 画像

  • Analysis of RFC3 recombinant protein. The purified recombinant protein shows a band at 41 kDa (calculated). Coomassie blue stained gel.

Recombinant Human RFC3 protein (ab40209) 使用論文

ab40209 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab40209.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"